Enterprise Value:
$3.66B+$52.04M(+1.44%)Summary
- As of today, RARE enterprise value is $3.66 billion, with a rise of +$52.04 million (+1.44%) during the most recent trading session on October 16, 2025.
- Over the past year, RARE enterprise value has dropped by -$1.95 billion (-34.77%).
- RARE enterprise value is now -67.74% below its all-time high of $11.34 billion.
Performance
RARE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RARE Enterprise Value Trends
| PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.4% | +1.6% | +1.6% |
| 1M1 Month | +13.4% | +15.2% | +15.2% |
| 3M3 Months | +21.3% | +24.4% | +24.4% |
| 6M6 Months | -0.3% | -0.3% | -2.9% |
| YTDYTD | -12.5% | -15.9% | -19.3% |
| 1Y1 Year | -34.8% | -38.5% | -41.1% |
| 5Y5 Years | -29.6% | -41.5% | -63.1% |
RARE Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | $3.66B | at high | $3.07B | +19.3% |
| 3M | 3-Month | $3.66B | at high | $2.92B | +25.3% |
| 6M | 6-Month | $4.38B | -16.4% | $2.92B | +25.3% |
| 1Y | 1-Year | $5.61B | -34.8% | $2.92B | +25.3% |
| 3Y | 3-Year | $5.63B | -35.0% | $2.37B | +54.3% |
| 5Y | 5-Year | $11.34B | -67.7% | $2.37B | +54.3% |
| All-Time | All-Time | $11.34B | -67.7% | $837M | +337.1% |
RARE Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $3.66B(-12.5%) |
| 2024 | $4.18B(-2.5%) |
| 2023 | $4.29B(+25.8%) |
| 2022 | $3.41B(-37.8%) |
| 2021 | $5.48B(-34.9%) |
| 2020 | $8.42B(+307.4%) |
| Date | Value |
|---|---|
| 2019 | $2.07B(+18.0%) |
| 2018 | $1.75B(-3.4%) |
| 2017 | $1.81B(-28.0%) |
| 2016 | $2.52B(-35.8%) |
| 2015 | $3.92B(+223.3%) |
| 2014 | $1.21B |
FAQ
- What is Ultragenyx Pharmaceutical Inc. enterprise value?
- What is the all-time high enterprise value for Ultragenyx Pharmaceutical Inc.?
- What is RARE enterprise value year-to-date change?
- What is Ultragenyx Pharmaceutical Inc. enterprise value year-on-year change?
What is Ultragenyx Pharmaceutical Inc. enterprise value?
The current enterprise value of RARE is $3.66B
What is the all-time high enterprise value for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high enterprise value is $11.34B
What is RARE enterprise value year-to-date change?
Ultragenyx Pharmaceutical Inc. enterprise value has changed by -$523.96M (-12.52%) since the beginning of the year
What is Ultragenyx Pharmaceutical Inc. enterprise value year-on-year change?
Over the past year, RARE enterprise value has changed by -$1.95B (-34.77%)